In order to characterize regulatory PCs in active MM patients and premalignant conditions (MGUS and SMM), the expression of LAG-3, PDL1, CD200, and PD1 receptors on purified PCs was assessed using flow cytometry. Here, LAG3 is linked to Miyoshi myopathy.